KRAS and non-small cell lung carcinoma: Some studies have demonstrated that EGFR and KRAS mutations were correlated with prognosis in early‐stage NSCLC,6, 7, 8 and numerous other oncogenic and tumor suppressor genes have been identified in the initiation and pathogenesis of NSCLC.